1. |
Satue M, Garcia-Martin E, Fuertes I, et al. Use of fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson’s disease patients[J]. Eye (Lond), 2013, 27(4): 507-514. DOI: 10.1038/eye.2013.4.
|
2. |
Garcia-Martin E, Satue M, Fuertes I, et al. Ability and reproducibility of fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson’s disease[J]. Ophthalmology, 2012, 119(10): 2161-2167. DOI: 10.1016/j.ophtha.2012.05.003.
|
3. |
Altintas O, Iseri P, Ozkan B, et al. Correlation between retinal morphological and functional findings and clinical severity in Parkinsons disease[J]. Doc Ophthalmol, 2008, 116(2): 137-146. DOI: 10.1007/s10633-007-9091-8.
|
4. |
Hajee ME, March WF, Lazzaro DR, et al. Inner retinal layer thinning in Parkinson’s disease[J]. Arch Ophthalmol, 2009, 127(6): 737-741. DOI: 10.1001/archophthalmol.2009.106.
|
5. |
Kim HG, Heo H, Park SW. Comparison of scanning laser polarimetry and opucal coherence tomography in prepenmetrtc glaucoma[J]. Optom Vis Sci, 2011, 88(1): 124-129. DOI: 10.1097/OPX.0b013e3181fdef9c.
|
6. |
Zhong Y, Shen X, Zhou X, et al. Blue-on-yellow perimetry and optical coherence tomography in patients wlth preperlmetrlc glaucoma[J]. Clin Exp Ophthalmol, 2009, 37(3): 262-269. DOI: 10.1111/ceo.2009.37.issue-3.
|
7. |
Reichmann H. Clinical criteria for the diagnosis of Parkinson’s disease[J]. Neurodegener Dis, 2010, 7(5): 284-290. DOI: 10.1159/000314478.
|
8. |
La Morgia C, Barboni P, Rizzo G, et al. Loss of temporal retinal nerve fibers in Parkinson’s disease: a mitochondrial pattern?[J]. Eur J Neurol, 2013, 20(1): 198-201. DOI: 10.1111/j.1468-1331.2012.03701.x.
|
9. |
Kim NR, Lee ES, Seong GJ, et al. Structure-function relationship and diagnostic value of macular ganglion cell complex measurement using fourier-domain OCT in glaucoma[J]. Invest Ophthalmol Vis Sci, 2010, 51(9): 4646-4651. DOI: 10.1167/iovs.09-5053.
|
10. |
Kirbas S, Turkyilmaz K, Tufekci A. Retinal nerve fiber layer thickness in Parkinson disease[J]. J Neuroophthalmol, 2013, 33(1): 62-65. DOI: 10.1097/WNO.0b013e3182701745.
|
11. |
Armstrong RA. Visual signs and symptoms of Parkinson’s disease[J]. Clin Exp Optom, 2008, 91(2): 129-138. DOI: 10.3390/s19030737.
|
12. |
Cubo E, Tedejo RP, Rodriguez Mendez V, et al. Retina thickness in Parkinson’s disease and essential tremor[J]. Mov Disord, 2010, 25(14): 2461-2477. DOI: 10.1002/mds.23215.
|
13. |
Satue M, Seral M, Otin S, et al. Retinal thinning and correlation with functional disability in patients with Parkinson’s disease[J]. Br J Ophthalmol, 2014, 98(3): 350-355. DOI: 10.1136/bjophthalmol-2013-304152.
|
14. |
Yavas GF, Yilmaz O, Ku¨sbeci T, et al. The effect of levodopa and dopamine agonists on optic nerve head in Parkinson disease[J]. Eur J Ophthalmol, 2007, 17(5): 812-816. DOI: 10.1177/112067210701700520.
|
15. |
Moschos MM, Tagaris G, Markopoulos I, et al. Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss[J]. Eur J Ophthalmol, 2011, 21(1): 24-29. DOI: 10.5301/EJO.2010.1318.
|
16. |
周娜磊, 安建斌, 马景学, 等. SD-OCT对正常人黄斑区视网膜厚度容积测量分析[J]. 中国实用眼科杂志, 2015, 33(2): 142-145. DOI: 10.3760/cma.j.issn.1006-4443.2015.02.012.Zhou NL, An JB, Ma J, et al. Analysis of macular thickness and cubic volume measured with SD-OCT in normal Subjects[J]. Chin J Pract Ophthalmol, 2015, 33(2): 142-145. DOI: 10.3760/cma.j.issn.1006-4443.2015.02.012.
|